GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » E10

Luyan Pharma Co (SZSE:002788) E10 : ¥1.01 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Luyan Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2024 was ¥0.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥1.01 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-16), Luyan Pharma Co's current stock price is ¥7.98. Luyan Pharma Co's E10 for the quarter that ended in Mar. 2024 was ¥1.01. Luyan Pharma Co's Shiller PE Ratio of today is 7.90.

During the past 13 years, the highest Shiller PE Ratio of Luyan Pharma Co was 9.09. The lowest was 6.88. And the median was 8.13.


Luyan Pharma Co E10 Historical Data

The historical data trend for Luyan Pharma Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co E10 Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.02

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.02 1.01

Competitive Comparison of Luyan Pharma Co's E10

For the Pharmaceutical Retailers subindustry, Luyan Pharma Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Luyan Pharma Co's Shiller PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Luyan Pharma Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Luyan Pharma Co's Shiller PE Ratio falls into.



Luyan Pharma Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Luyan Pharma Co's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.22/115.2271*115.2271
=0.220

Current CPI (Mar. 2024) = 115.2271.

Luyan Pharma Co Quarterly Data

per share eps CPI Adj_EPS
201212 0.940 95.237 1.137
201312 1.130 97.624 1.334
201412 1.140 99.000 1.327
201503 0.080 99.900 0.092
201506 0.124 99.500 0.144
201509 0.088 100.500 0.101
201512 0.139 100.600 0.159
201603 0.073 102.200 0.082
201606 0.095 101.400 0.108
201609 0.069 102.400 0.078
201612 0.110 102.600 0.124
201703 0.066 103.200 0.074
201706 0.115 103.100 0.129
201709 0.137 104.100 0.152
201712 0.100 104.500 0.110
201803 0.093 105.300 0.102
201806 0.140 104.900 0.154
201809 0.158 106.600 0.171
201812 0.121 106.500 0.131
201903 0.130 107.700 0.139
201906 0.214 107.700 0.229
201909 0.230 109.800 0.241
201912 0.130 111.200 0.135
202003 0.150 112.300 0.154
202006 0.220 110.400 0.230
202009 0.250 111.700 0.258
202012 0.130 111.500 0.134
202103 0.170 112.662 0.174
202106 0.220 111.769 0.227
202109 0.210 112.215 0.216
202112 0.190 113.108 0.194
202203 0.180 114.335 0.181
202206 0.250 114.558 0.251
202209 0.211 115.339 0.211
202212 0.240 115.116 0.240
202303 0.210 115.116 0.210
202306 0.280 114.558 0.282
202309 0.180 115.339 0.180
202312 0.261 114.781 0.262
202403 0.220 115.227 0.220

Add all the adjusted EPS together and divide 10 will get our e10.


Luyan Pharma Co  (SZSE:002788) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Luyan Pharma Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=7.98/1.01
=7.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Luyan Pharma Co was 9.09. The lowest was 6.88. And the median was 8.13.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Luyan Pharma Co E10 Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Luyan Pharma Co (SZSE:002788) Business Description

Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Executives
Zhu Ming Guo Executives
Yang Cong Jin Directors, executives
Lei Ming Directors, executives
Li Wei Yang Executives
Cai Mei Zhen Supervisors
Li Cui Ping Supervisors
Wu Jin Xiang Directors, executives
Zhang Jun Ying Executives
Wu Huo Lu Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines